New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 18, 2023 - Orasis Pharmaceuticals announced the FDA approval of Qlosi (pilocarpine), for the treatment of presbyopia in adults.
Download PDF
Return to publications
